Trinity Biotech (TRIB) Receives Nasdaq Non-Compliance Notice
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement
April 24, 2023 5:50 PM EDTDUBLIN, Ireland, April 24, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the Company), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that on April 19, 2023 the Company received notice (the Notice) from the Nasdaq Stock Market LLC (Nasdaq) that the Company is not in compliance with Nasdaq Listing Rule 555(a)(2), as the minimum bid price of the Companys American depositary shares (ADSs) has been below US $1.00 per share for 30 consecutive business days. The Notice has no immediate effect on the listing of the Companys ADSs,... More
